Arcus Biosciences, Inc. (RCUS)
NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
As of 10:20AM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 1.45B |
| Enterprise Value | 702.70M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 10.09 |
| Price/Book (mrq) | 3.14 |
| Enterprise Value/Revenue | 6.01 |
| Enterprise Value/EBITDA | -2.41 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.85 |
| 52-Week Change 3 | -17.78% |
| S&P500 52-Week Change 3 | 25.77% |
| 52 Week High 3 | 25.47 |
| 52 Week Low 3 | 12.95 |
| 50-Day Moving Average 3 | 17.19 |
| 200-Day Moving Average 3 | 17.35 |
Share Statistics
| Avg Vol (3 month) 3 | 763.22k |
| Avg Vol (10 day) 3 | 517.39k |
| Shares Outstanding 5 | 90.95M |
| Implied Shares Outstanding 6 | 90.95M |
| Float 8 | 54.42M |
| % Held by Insiders 1 | 40.82% |
| % Held by Institutions 1 | 59.47% |
| Shares Short (Apr 15, 2024) 4 | 6.84M |
| Short Ratio (Apr 15, 2024) 4 | 10.43 |
| Short % of Float (Apr 15, 2024) 4 | 15.62% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 7.52% |
| Shares Short (prior month Mar 15, 2024) 4 | 7.98M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | -262.39% |
| Operating Margin (ttm) | -293.55% |
Management Effectiveness
| Return on Assets (ttm) | -17.42% |
| Return on Equity (ttm) | -54.87% |
Income Statement
| Revenue (ttm) | 117M |
| Revenue Per Share (ttm) | 1.58 |
| Quarterly Revenue Growth (yoy) | -8.80% |
| Gross Profit (ttm) | N/A |
| EBITDA | -332M |
| Net Income Avi to Common (ttm) | -307M |
| Diluted EPS (ttm) | -4.15 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 759M |
| Total Cash Per Share (mrq) | 8.35 |
| Total Debt (mrq) | 121M |
| Total Debt/Equity (mrq) | 26.19% |
| Current Ratio (mrq) | 4.52 |
| Book Value Per Share (mrq) | 6.12 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -306M |
| Levered Free Cash Flow (ttm) | -187.75M |
© 2024 Yahoo. All rights reserved.